Influence of the thromboxane antagonist BM 13.177 on the irrachidonic acid-induced increase in pulmonary vascular resistance and permeability in rabbit lungs

This publication has 23 references indexed in Scilit:

• The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug
  Thrombosis Research, 1984
• Inhibition of cyclooxygenase production does not prevent arachidonate from increasing extravacular lung water and albumin in an isolated dog lung
  Prostaglandins, Leukotrienes and Medicine, 1984
• BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN
  The Lancet, 1984
• Total profiling by GC/NICIMS of the major cyclo-oxygenase products from antigen and leukotriene-challenged guinea-pig lung
  Biochemical Pharmacology, 1984
• Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets
  Thrombosis Research, 1984
• Increased pulmonary vascular resistance and permebility due to arachidonate metabolism in isolated rabbit lungs
  Prostaglandins, 1982
• Differences in biological activity of arachidonic acid in perfused lungs from guinea pig, rat and man
  European Journal of Pharmacology, 1980
• Pulmonary capillary filtration and reflection coefficients in the adult rabbit
  Microvascular Research, 1977
• Vascular responses to arachidonic acid in the perfused canine lung.
  Circulation Research, 1976
• Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea‐pig lungs
  British Journal of Pharmacology, 1973